Oral minoxidil and spironolactone versus topical minoxidil for female pattern hair loss

Phase 2

• Conditions: Female pattern hair loss; C17.800.329.937.122

• Registration Number: RBR-6c26hx
• Lead Sponsor: Faculdade Medicina da Universidade Estadual Paulista - UNESP

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-01-09
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Patients with female pattern hair loss; age between 20 and 55 years

Exclusion Criteria

Patients who had been treated for hair loss in the last 6 months, patients with hipertension, heart and kidney disease, patients with other causes of hair loss tha female pattern hair loss, patients in childbearing age who not using contraception;

Study & Design

• Study Type: Intervention
• Study Design: Not specified